Clinical Trial Update: Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing intrathecal versus intravenous dexmedetomidine in patients undergoing transurethral resection of the prostate; current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Transurethral Resection of the Prostate

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Tanta University | Conditions: Dexmedetomidine, Transurethral Resection of Prostate | Phase 4 | Status: UNKNOWN